{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:56:26Z","timestamp":1791924986952,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03890-3","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:48:31Z","timestamp":1749815311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Siyuan","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"issue":"8","key":"3890_CR1","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer TB, Bandi P, Freedman ND, Smith RA, Travis WD, Jemal A, Siegel RL. Lung cancer statistics, 2023. Cancer. 2024;130(8):1330\u201348.","journal-title":"Cancer"},{"issue":"3","key":"3890_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10549-019-05357-y","volume":"177","author":"SE Nam","year":"2019","unstructured":"Nam SE, Lim W, Jeong J, Lee S, Choi J, Park H, Jung YS, Jung SP, Bae SY. The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean breast Cancer society registry. Breast Cancer Res Treat. 2019;177(3):669\u201378.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3890_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1182\/blood.2024024371","volume":"144","author":"O Landgren","year":"2024","unstructured":"Landgren O, Prior TJ, Masterson T, Heuck C, Bueno OF, Dash AB, Einsele H, Goldschmidt H, Knop S, Li C, et al. EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma. Blood. 2024;144(4):359\u201367.","journal-title":"Blood"},{"key":"3890_CR4","doi-asserted-by":"publisher","first-page":"105109","DOI":"10.1016\/j.ebiom.2024.105109","volume":"103","author":"J Zheng","year":"2024","unstructured":"Zheng J, Qin C, Wang Q, Tian D, Chen Z. Circulating tumour DNA-Based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis. EBioMedicine. 2024;103:105109.","journal-title":"EBioMedicine"},{"issue":"3","key":"3890_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.21037\/jgo-24-81","volume":"15","author":"C Eslinger","year":"2024","unstructured":"Eslinger C, Wu C, Ahn DH. Minimal residual disease monitoring via ctdna: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature. J Gastrointest Oncol. 2024;15(3):1341\u20137.","journal-title":"J Gastrointest Oncol"},{"issue":"16","key":"3890_CR6","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1158\/1078-0432.CCR-24-0226","volume":"30","author":"S Slater","year":"2024","unstructured":"Slater S, Bryant A, Aresu M, Begum R, Chen HC, Peckitt C, Lazaro-Alcausi R, Carter P, Anandappa G, Khakoo S, et al. Tissue-Free liquid biopsies combining genomic and methylation signals for minimal residual disease detection in patients with early colorectal Cancer from the UK TRACC part B study. Clin Cancer Res. 2024;30(16):3459\u201369.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3890_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-024-02006-x","volume":"23","author":"P Yue","year":"2024","unstructured":"Yue P, Bie F, Zhu J, Gao LR, Zhou Z, Bai G, Wang X, Zhao Z, Xiao ZF, Li Y, et al. Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma. Mol Cancer. 2024;23(1):96.","journal-title":"Mol Cancer"},{"issue":"1","key":"3890_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12916-023-02849-z","volume":"21","author":"R Zhong","year":"2023","unstructured":"Zhong R, Gao R, Fu W, Li C, Huo Z, Gao Y, Lu Y, Li F, Ge F, Tu H, et al. Accuracy of minimal residual disease detection by Circulating tumor DNA profiling in lung cancer: a meta-analysis. BMC Med. 2023;21(1):180.","journal-title":"BMC Med"},{"issue":"12","key":"3890_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","volume":"7","author":"AA Chaudhuri","year":"2017","unstructured":"Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, et al. Early detection of molecular residual disease in localized lung Cancer by Circulating tumor DNA profiling. Cancer Discov. 2017;7(12):1394\u2013403.","journal-title":"Cancer Discov"},{"issue":"15","key":"3890_CR10","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1158\/1078-0432.CCR-21-3044","volume":"28","author":"L Xia","year":"2022","unstructured":"Xia L, Mei J, Kang R, Deng S, Chen Y, Yang Y, Feng G, Deng Y, Gan F, Lin Y, et al. Perioperative ctDNA-Based molecular residual disease detection for Non-Small cell lung cancer: A prospective multicenter cohort study (LUNGCA-1). Clin Cancer Res. 2022;28(15):3308\u201317.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3890_CR11","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1158\/2159-8290.CD-21-1486","volume":"12","author":"J-T Zhang","year":"2022","unstructured":"Zhang J-T, Liu S-Y, Gao W, Maggie S-Y, Yan HH, Ji L, Chen Y, Gong Y, Lu H-L, Lin J-T, et al. Longitudinal undetectable molecular residual disease defines potentially cured population in localized Non-Small cell lung Cancer. Cancer Discov. 2022;12(7):1690\u2013701.","journal-title":"Cancer Discov"},{"issue":"10","key":"3890_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.ccell.2023.08.010","volume":"41","author":"K Chen","year":"2023","unstructured":"Chen K, Yang F, Shen H, Wang C, Li X, Chervova O, Wu S, Qiu F, Peng D, Zhu X, et al. Individualized tumor-informed Circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer. Cancer Cell. 2023;41(10):1749\u2013e17621746.","journal-title":"Cancer Cell"},{"issue":"05","key":"3890_CR13","first-page":"416","volume":"32","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zhou W, Xiong J, Li Q, Zhao Q, Liang D, Ai C. Predictive efficacy of minimal residual disease detection based on ctdna on survival of non-small cell lung cancer after radical surgery. J Reg Anat Oper Surg. 2023;32(05):416\u201320.","journal-title":"J Reg Anat Oper Surg"},{"issue":"9","key":"3890_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jtho.2023.05.027","volume":"18","author":"HA Jung","year":"2023","unstructured":"Jung HA, Ku BM, Kim YJ, Park S, Sun JM, Lee SH, Ahn JS, Cho JH, Kim HK, Choi YS, et al. Longitudinal monitoring of Circulating tumor DNA from plasma in patients with curative resected stages I to IIIA EGFR-Mutant Non-Small cell lung Cancer. J Thorac Oncol. 2023;18(9):1199\u2013208.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"3890_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.ccell.2023.09.007","volume":"41","author":"Y Pan","year":"2023","unstructured":"Pan Y, Zhang JT, Gao X, Chen ZY, Yan B, Tan PX, Yang XR, Gao W, Gong Y, Tian Z, et al. Dynamic Circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients. Cancer Cell. 2023;41(10):1763\u2013e17731764.","journal-title":"Cancer Cell"},{"key":"3890_CR16","doi-asserted-by":"publisher","first-page":"1098128","DOI":"10.3389\/fonc.2023.1098128","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang Y, Zhang S, Wang S, Yang P, Liu C. Investigate the application of postoperative ctdna-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer\u2013A retrospective study of ctdna. Front Oncol. 2023;13:1098128.","journal-title":"Front Oncol"},{"key":"3890_CR17","doi-asserted-by":"crossref","unstructured":"Fu R, Xiong Y, Cai M, Li F, Chen R, Wu Y, Zhong W. Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de Novo MET amplification. Front Med 2024.18(4):735-743.","DOI":"10.1007\/s11684-024-1060-z"},{"issue":"1","key":"3890_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.21037\/jtd-23-507","volume":"16","author":"HJ Li","year":"2024","unstructured":"Li HJ, Zhang JT, Dong S, Yang XN, Cui SR, Wu YL, Zhong WZ. CtDNA based molecular residual disease outcompetes carcinoembryonic antigen in predicting postoperative recurrence of non-small cell lung cancer. J Thorac Dis. 2024;16(1):423\u20139.","journal-title":"J Thorac Dis"},{"key":"3890_CR19","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed). 2021;372:n71.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"11","key":"3890_CR20","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.jtho.2021.07.001","volume":"16","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li J, Chang S, Dong Y, Che G. Risk and influencing factors for subsequent primary lung Cancer after treatment of breast cancer: A systematic review and two Meta-Analyses based on four million cases. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2021;16(11):1893\u2013908.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"4","key":"3890_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"issue":"7109","key":"3890_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Res ed). 1997;315(7109):629\u201334.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"5","key":"3890_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40291-024-00725-x","volume":"28","author":"C Chen","year":"2024","unstructured":"Chen C, Douglas MP, Ragavan MV, Phillips KA, Jansen JP. Clinical validity and utility of Circulating tumor DNA (ctDNA) testing in advanced Non-small cell lung Cancer (aNSCLC): A systematic literature review and Meta-analysis. Mol Diagn Ther. 2024;28(5):525\u201336.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"3890_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00432-023-05550-z","volume":"150","author":"J Lu","year":"2024","unstructured":"Lu J, Feng Y, Guo K, Sun L, Ruan S, Zhang K. Prognostic value of preoperative Circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2024;150(1):25.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3890_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12916-022-02681-x","volume":"20","author":"H Shen","year":"2022","unstructured":"Shen H, Jin Y, Zhao H, Wu M, Zhang K, Wei Z, Wang X, Wang Z, Li Y, Yang F, et al. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer. BMC Med. 2022;20(1):480.","journal-title":"BMC Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03890-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03890-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03890-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:48:32Z","timestamp":1749815312000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03890-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3890"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03890-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed in studies that involved human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Consent to participate was not applicable for this type of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}